Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
about
Malignant gliomas: old and new systemic treatment approachesTemozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.Impact of imaging measurements on response assessment in glioblastoma clinical trialsPhase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomasTemozolomide in malignant gliomaComparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas.Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.CNS Anticancer Drug Discovery and Development Conference White Paper.Chemotherapy for malignant glioma.Chemotherapy in the treatment of malignant gliomas.Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.New developments in the treatment of malignant gliomas.Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium.Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group.The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.Radiotherapy followed by adjuvant temozolomide with or without neoadjuvant ACNU-CDDP chemotherapy in newly diagnosed glioblastomas: a prospective randomized controlled multicenter phase III trial.Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma.Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.
P2860
Q26744387-CE16D827-D27C-4CEA-B34C-1D711B0B40CDQ33366011-80B63576-4DD7-45C5-9785-0C181225E905Q33379701-E4829BCF-2437-4BC1-BE35-52859B8C5277Q34331328-5B3D8C3F-4D1D-4DE3-A8D4-19C6B37F91D8Q34358041-D623E091-B1F3-4ECA-84AF-E8354EFBBCEDQ34623633-040FF943-4E87-48F5-A740-8A3FCE986EC3Q35800552-8F546D42-AF6C-4147-B891-10280603EFB7Q35920319-8D1EF34F-C2EF-4F3C-A0C6-527A735D5786Q36089590-1BC690C8-6978-44BD-A92C-F3366036EDA8Q36307802-A2B8154D-F026-42DA-96A8-B59FB182C6A0Q36499238-55A939AC-5DBC-435B-AF1F-282B0429BC69Q36668246-707136B3-F3DF-4F97-AA10-4ABEEB4F6948Q36972696-9ABCF88B-BA56-4CDD-AEC7-86DA00EA3034Q37152009-17570A66-46F5-4F0D-869C-BA3F8E8C526EQ37592456-9EEF4749-9E54-4635-A4F6-7F1459A99341Q38093776-382CC18C-D4FB-4185-8960-66A1FBE721A4Q39820287-D090A484-106E-4E61-9140-578B816A86F4Q45166511-8792E2A1-56B2-43E3-8DAA-C5D0AB65CD03Q47987124-C241C9B2-6616-44DF-B6B6-DF50ADE93652
P2860
Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@ast
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@en
type
label
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@ast
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@en
prefLabel
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@ast
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@en
P2093
P2860
P1433
P1476
Phase 2 study of BCNU and temo ...... Brain Tumor Consortium study.
@en
P2093
H Ian Robins
Harry S Greenberg
Howard A Fine
Karen L Fink
Kenneth R Hess
Kurt A Jaeckle
Larry Junck
M Kelly Nicholas
Michael D Prados
P2860
P356
10.1215/S1152851703000309
P577
2004-01-01T00:00:00Z